This study is looking at how safe and effective a medicine called orforglipron is for people with Type 2 Diabetes (T2D). T2D is a condition where your body can't control sugar levels in the blood well. Participants in this study have T2D and their sugar levels are not well controlled with insulin glargine, with or without medications like metformin or SGLT-2 inhibitors (a type of medicine that helps kidneys remove sugar from the body). The study will last about 46 weeks and may require up to 20 doctor visits.
- Time Commitment: The study lasts for around 46 weeks with up to 20 visits.
- Eligibility: Participants need to have T2D, and have specific criteria for sugar levels and body weight.
- Health Conditions: People with serious heart or liver issues or pancreatitis should not participate.
Before joining, consider if you can commit to the schedule and if your health condition fits the requirements. Always discuss with your doctor if you’re interested in participating in this study.
How understandable was the trial content above?
Hard to understand
Easy to understand